Yongping Song Selected Research

Yongping Song Research Topics

Disease

57	Neoplasms (Cancer) 03/2024 - 08/2013
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2012
15	Multiple Myeloma 11/2023 - 01/2007
11	Leukemia 03/2024 - 04/2011
11	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 01/2018
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 01/2015
10	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 10/2012
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 01/2014
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 10/2007
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2016
6	Lymphoma (Lymphomas) 05/2023 - 01/2019
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 11/2007
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 08/2014
5	Infections 01/2022 - 12/2013
5	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 02/2012
4	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2017
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 11/2013
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2014
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 11/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2014
3	Melanoma (Melanoma, Malignant) 01/2023 - 08/2015
3	Hodgkin Disease (Hodgkin's Disease) 04/2020 - 01/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 01/2024
2	Inflammation (Inflammations) 01/2024 - 01/2016
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023 - 01/2021
2	Adenocarcinoma of Lung 01/2023 - 08/2016
2	Chronic Hepatitis B 12/2022 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 12/2022 - 01/2016
2	Thyroid Neoplasms (Thyroid Cancer) 09/2022 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 05/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2022 - 01/2018
2	Extranodal NK-T-Cell Lymphoma 10/2021 - 07/2014
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Papillary Thyroid Cancer 06/2019 - 11/2016
2	Hematologic Diseases (Blood Diseases) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

13	Chimeric Antigen ReceptorsIBA 02/2024 - 10/2017
10	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2016
9	CytokinesIBA 02/2024 - 01/2016
9	Rituximab (Mabthera)FDA Link 01/2024 - 04/2014
8	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2015
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
6	Bispecific AntibodiesIBA 05/2024 - 01/2019
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2014
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 03/2010
5	AntibodiesIBA 10/2023 - 01/2016
5	Dexamethasone (Maxidex)FDA LinkGeneric 05/2023 - 04/2014
5	Bortezomib (Velcade)FDA Link 01/2023 - 01/2007
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 10/2007
5	Inosine Triphosphate (ITP)IBA 01/2022 - 02/2012
5	Arsenic Trioxide (Trisenox)FDA Link 06/2020 - 10/2012
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2017
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2023 - 01/2020
4	Monoclonal AntibodiesIBA 10/2023 - 11/2019
4	Prednisone (Sone)FDA LinkGeneric 01/2023 - 11/2017
4	Phosphotransferases (Kinase)IBA 02/2016 - 08/2013
4	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 10/2007
3	ChemokinesIBA 02/2024 - 11/2022
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024 - 01/2016
3	Immunoglobulin G (IgG)IBA 01/2024 - 01/2020
3	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 08/2013
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 04/2014
3	olverembatinibIBA 01/2023 - 01/2022
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 04/2014
3	Decitabine FDA Link 01/2023 - 01/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2014
3	sintilimabIBA 10/2021 - 01/2019
3	Thalidomide (Thalomid)FDA Link 01/2020 - 10/2014
3	EnzymesIBA 12/2019 - 08/2013
3	Interleukin-2 (IL2)IBA 01/2018 - 10/2014
3	Asparaginase (Elspar)FDA Link 11/2017 - 07/2014
3	InterferonsIBA 04/2016 - 10/2014
2	AntigensIBA 03/2024 - 01/2022
2	LigandsIBA 02/2024 - 01/2021
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2024 - 10/2023
2	Biosimilar PharmaceuticalsIBA 01/2024 - 01/2020
2	NivolumabIBA 01/2024 - 01/2021
2	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2022
2	Small Cytoplasmic RNAIBA 05/2023 - 12/2022
2	Long Noncoding RNAIBA 01/2023 - 08/2016
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2023 - 10/2022
2	zanubrutinibIBA 12/2022 - 10/2021
2	ibrutinibIBA 01/2022 - 08/2013
2	Axitinib (AG 013736)IBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 06/2016
2	plerixafor FDA Link 01/2020 - 01/2018
2	Immunomodulating AgentsIBA 01/2020 - 11/2019
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2019

Therapy/Procedure

51	Therapeutics 01/2024 - 11/2010
31	Immunotherapy 05/2024 - 01/2014
19	Hematopoietic Stem Cell Transplantation 01/2023 - 03/2009
15	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
6	Radiotherapy 05/2023 - 07/2014
4	Transplantation 01/2022 - 12/2013
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2023 - 01/2020
3	Stem Cell Transplantation 01/2023 - 12/2015
3	Salvage Therapy 06/2020 - 11/2007
2	Neck Dissection (Radical Neck Dissection) 06/2019 - 11/2016